Figure 3. The distinct TME features and anticancer immune activities of the two subtypes. (A, B) Violin plots showing the immune score and tumor purity score of each subtype. (C, D) Immune infiltration in TCGA-LUAD samples. (E) Anticancer immune activity of the seven-step cancer-immunity cycle. (F) Heatmap of the 36 hallmark pathways differentially enriched between different inflammation subtypes identified by GSVA.